Close search

Latest news

New Vancomycin Obese, Hemodialysis and Complex Models Released
25 Mar 2019 | Company Announcement

New Vancomycin Obese, Hemodialysis and Complex Models Released

Note: The new vancomycin dosing guidelines have been officially released. Learn what's changed and how they'll impact you by reading our guide to the new vancomycin dosing changes here. DoseMe today is excited to announce we have released three new adult vancomycin models to help you optimize vancomycin...

Read more
DoseMe Joins Tabula Rasa HealthCare
8 Jan 2019 | Latest News

DoseMe Joins Tabula Rasa HealthCare

Tabula Rasa HealthCare (TRHC) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, has completed its acquisition of DoseMe on January 2, 2019. DoseMeRx’s precision dosing capabilities will join TRHC's suite of technology and consulting services for healthcare organizations, 

Read more
Vancomycin Dosing in Pediatrics
19 Dec 2018 | Blog

Vancomycin Dosing in Pediatrics

Note: The new vancomycin dosing guidelines have been officially released. Learn what's changed and how they'll impact you by reading our guide to the new vancomycin dosing changes here. Vancomycin is a commonly prescribed antibiotic used to treat children and adults with serious infections....

Read more
Tabula Rasa HealthCare to Acquire DoseMe
4 Dec 2018 | Latest News

Tabula Rasa HealthCare to Acquire DoseMe

DoseMe, the first company in the world to design a precision dosing platform - DoseMeRx - specifically developed for clinical practice today announced it will be acquired by Tabula Rasa HealthCare, Inc (NASDAQ:TRHC) a healthcare technology company advancing the field of medication safety. Tabula Rasa HealthCare (“TRHC”)...

Read more
From Trough to AUC Vanco Webinar 💊Watch now →

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2020 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.